Medtronic Boosts FY24 Outlook - Update

February 20, 2024 — 07:05 am EST

Written by RTTNews.com for RTTNews

(RTTNews) - While reporting financial results for the third quarter on Tuesday, medical devices maker Medtronic plc. (MDT) raised its adjusted earnings and organic revenue growth guidance for the full-year 2024, based on third quarter performance.

For fiscal 2023, the company now projects adjusted earnings in a range of $5.19 to $5.21 per share on organic revenue growth of 4.75 to 5.0 percent.

Previously, the company expected adjusted earnings in the range of $5.13 to $5.19 per share on organic revenue growth of 4.75 percent.

On average, 32 analysts polled by Thomson Reuters expect the company to report earnings of $5.16 per share for the quarter. Analysts' estimates typically exclude special items.

"In addition to delivering durable sales growth, we also drove improvements to our margins, as our cost efficiency programs helped to offset the impact of inflation, tax, and currency, contributing to our EPS and cash flow performance in the quarter," said Karen Parkhill, Medtronic chief financial officer.

For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com

RTTNews

Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.

Medtronic Boosts FY24 Outlook - Update

Tags

Latest Articles